Navigation Links
Irritable Bowel Syndrome Takes Center Stage at Yakult's 17th Intestinal Flora Symposium
Date:11/3/2008

- Probiotics may offer sufferers non-drug option for symptom relief -

TOKYO, Nov. 3 /PRNewswire/ -- Last Friday, the 17th Annual Symposium on Intestinal Flora at Yakult World Headquarters Hall in Tokyo gathered physicians, researchers and company associates from 19 countries, including the U.S. This year's theme, "Intestinal Microbiota and Functional Gastrointestinal Disorders" focused on brain-gut interactions and Irritable Bowel Syndrome, which is believed to be the "entry illness" that leads to various digestive diseases.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070911/YAKULTLOGO)

IBS affects up to 25% of the world population and roughly one in five Americans. It is caused by an inflammatory reaction in the intestines, often triggered by stress, and results in a change to gut microflora. These mechanisms and other new discoveries about the brain-gut relationship were presented to a packed room of more than 500 attendees.

"Probiotics show promise for manipulating gut microflora," predicated Stephen M. Collins of McMaster University, Canada concluding his presentation, 'The Influence of Commensally Bacteria on the Gut-Brain Axis.' Probiotics are appealing for IBS sufferers since they are not drugs, have no side effects and can help maintain intestinal balance.

Other presentations included: "Stress and brain-gut interactions in IBS," by Shin Fukudo (Tohoku University, Japan); "Intestinal inflammation and motor function," by Hiroshi Ozaki (University of Tokyo); "Effect of stress-related peptides on colonic motility," by Shigeru Yamato (International Medical Center of Japan, Konodai Hospital); "Probiotics and IBS," by Eamonn M. Quigley (Cork University, Ireland); "Stress and intestinal microbiota," by Michael T. Bailey (Ohio State University); and "IBS: medicine and probiotics," by Mitsuhisa Kawai (Yakult Central Institute for Microbiological Research, Japan).

Yakult Honsha Ltd., Co. developed the symposium in 1992 when probiotics research gripped doctors and scientists abroad. Since then, it has become one of the world's most prominent forums discussing the hottest research and advancements in the probiotics field. The symposium is free and open to the public every year; in Japan no registration is required. Interested participants in the U.S. can reserve a seat for future symposia by contacting Yakult USA Inc. at science@yakultusa.com.

Founded by Dr. Minora Shirota, Yakult Honsha Ltd., Co. was established in Japan in 1955 and is regarded as the world's pioneer of probiotics. The company produces Yakult, the original probiotic dairy drink containing the exclusive strain Lactobacillus casei Shirota. Scientists all over the world continue to confirm and expand knowledge regarding the health benefits of Yakult and probiotics. Yakult U.S.A. Inc. is a subsidiary of Tokyo-based Yakult Honsha Co., Ltd. and is headquartered in Torrance, CA. It supports Yakult's activities in the United States and Canada. For more information, visit http://www.yakultusa.com.


'/>"/>
SOURCE Yakult U.S.A. Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Allergic disease linked to irritable bowel syndrome
2. Abuse history affects pain regulation in women with irritable bowel syndrome
3. Harnessing the Mind to Manage Irritable Bowel Syndrome
4. Allergy Disorders Linked With Irritable Bowel Syndrome
5. Antidepressant found to alleviate symptoms of irritable bowel syndrome in adolescents
6. AMITIZA 8 mcg now available to treat irritable bowel syndrome
7. ReachMD XM 157 Announces Medical Information Feature on Irritable Bowel Syndrome, Its Treatments, and the Role of Probiotics
8. Elsevier announces new journal on inflammatory bowel diseases
9. C-diff infection 4 times more likely to kill patients with inflammatory bowel disease
10. Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients
11. Threshold for bowel surgery may be too high, warn experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... ... , ... While James Earl Jones is known for myriad roles on stage ... "Front Page". One of the forthcoming episodes examines mammogram techniques; a very important part ... part due to early detection. Like any other disease, treatments have a much higher ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/4/2016)... , ... December 04, 2016 , ... Responsible dental care ... must brush properly to achieve optimal results. This important necessity inspired an inventor from ... for a way to ensure that people break or avoid bad techniques of brushing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Nov. 29, 2016 Several leading ... by Accera, Inc. at 11 a.m. EST ... International Conference on Clinical Trials for Alzheimer,s Disease (CTAD). ... metabolism in Alzheimer,s disease and therapeutic targets that address ... "Following the recent failure of another therapy targeting ...
(Date:12/5/2016)... Dec 5, 2016 Research and Markets ... Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End ... Forecasts to 2021" report to their offering. ... , , ... Million in 2021 from USD 574.8 Million in 2016, growing at ...
(Date:12/5/2016)... December 5, 2016 According to a new report published ... Application - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", the global ... reach $5,255 million by 2022, growing at a CAGR of 6.4% from 2016 ... four-fifths share. Continue Reading ... ...
Breaking Medicine Technology: